Contactless Measurement of Heart Rate, Heart Rate Variability, Breathing Rate and Blood Pressure Using Remote Photoplethysmography
NCT ID: NCT06829615
Last Updated: 2025-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
132 participants
INTERVENTIONAL
2025-05-06
2025-10-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Contactless Measurement of Heart Rate, Heart Rate Variability and Breathing Rate Using Remote Photoplethysmography
NCT05889832
Non-contact Blood Pressure and SpO2 Measurement Based on Image Sensor
NCT06204822
Validity and Reliability of Optical Heart Rate Sensors
NCT05525000
Evaluation of Performance, Usability, and Reliability of a Novel Device for Continuous Collection of Physiological Data
NCT03257189
Feasibility of Remote Evaluation and Monitoring of Acoustic Pathophysiological Signals With External Sensor Technology
NCT04693091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Physiological parameters, including HR, HRV, BR, and BP, will be measured and estimated using remote photoplethysmography (rPPG) based on a 1-minute facial video analysis processed by Shen.AI software.
Throughout all measurements, participants will be connected to a reference device that records ECG while simultaneously measuring chest impedance (impedance pneumography). Additionally, each participant will wear a respiratory belt transducer. Depending on the measurement type, the participant's blood pressure will be assessed using either an auscultatory or an automatic blood pressure monitor. The study will be conducted on a diverse group of participants, varying in blood pressure, gender, age, skin phototype, and BMI.
For each measured parameter, results obtained from both methods will be compared using Bland-Altman analysis or non-parametric limits of agreement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HR, HRV, BR, and BP measured using Shen.AI and reference methods
Shen.AI
Contactless measurement of heart rate, heart rate variability, breathing rate, and blood pressure using Shen.AI software and reference methods.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Shen.AI
Contactless measurement of heart rate, heart rate variability, breathing rate, and blood pressure using Shen.AI software and reference methods.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to read and write in Polish or English
* Ability to operate a mobile device and a laptop without requiring glasses
* Ability to understand the study procedure
* Ability to communicate and follow instructions from the study personnel
* Provision of written informed consent for participation in the study and for the processing of personal data by the research team and the study sponsor
* Blood pressure values in accordance with the distribution of the study group
Exclusion Criteria
* Age below 18 years
* Failure to provide the required information in the participant's informational questionnaire
* Non-compliance with the study procedure or instructions from the study personnel
* Extensive facial skin damage (e.g., abrasions, wounds, burns)
* A disease process affecting a significant portion of the face
* Extensive facial dressing
* Extensive facial tattoos or facial painting
* Significant facial deformity (e.g., tumor)
* Inability to maintain a stable head position during measurement
* Persistent cough preventing stillness during measurement
* Respiratory dysfunction such as dyspnea, irregular or shallow breathing
* Diagnosed arrhythmia (except for sinus bradycardia or sinus tachycardia)
* Moderate or severe anemia
* Diagnosed conditions such as left ventricular systolic dysfunction, aortic valve stenosis, or other cardiac or circulatory diseases leading to low stroke volume, low pulse amplitude, or pulsus paradoxus
* Implanted cardiac pacemaker
* Blood pressure difference between arms exceeding 15 mmHg for systolic pressure or 10 mmHg for diastolic pressure
* Inability to determine blood pressure in both arms
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SHEN.AI spółka z ograniczoną odpowiedzialnością oddział w Polsce
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Justyna Chojdak-Łukasiewicz, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Wroclaw Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OVO MEDICAL Sp. z o.o.
Wroclaw, Lower Silesian Voivodeship, Poland
Przychodnia rehabilitacyjna R-MED
Wroclaw, Lower Silesian Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MDF-01-008-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.